A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis
Clinical trial NCT02531178 · COMPLETED
Trial details
- NCT number
- NCT02531178
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-02-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.